reviewThe LancetJan 1, 2003Closed access

Overview of the main outcomes in breast-cancer prevention trials

JCJack CuzickTPT.J. PowlesUVUmberto VeronesiJFJohn ForbesRPRobert P. Edwards

Cancer Research UK · Cancer Research UK Technology · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

962
total citations
FWCI
54.71
Percentile
100%
References
10
Citations per year

Authors

7

Topics & keywords

Topics
Keywords
  • Tamoxifen
  • Raloxifene
  • Medicine
  • Breast cancer
  • Oncology
  • Hazard ratio
  • Internal medicine
  • Placebo
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding